• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An ATP-selective, lanthanide complex luminescent probe?
  Xiao Liu,Jun Xu,Yinyun Lv,Wenyu Wu,Weisheng Liu,Yu Tang Dalton Trans., 2013,42, 9840-9846
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Anisoles

4-(4-Methoxy-2-methylphenyl)butanoic Acid (CAS No. 6307-30-8): A Comprehensive Overview

4-(4-Methoxy-2-methylphenyl)butanoic acid (CAS No. 6307-30-8) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 4-(4-methoxy-2-methylphenyl)butyric acid, is characterized by its unique structural features, which include a substituted phenyl ring and a carboxylic acid group. These properties make it an attractive candidate for various applications, particularly in the development of novel therapeutic agents.

The molecular formula of 4-(4-methoxy-2-methylphenyl)butanoic acid is C11H14O3, and its molecular weight is 194.22 g/mol. The compound is a white crystalline solid at room temperature and is soluble in common organic solvents such as ethanol and dimethyl sulfoxide (DMSO). Its chemical structure consists of a butanoic acid chain attached to a 4-methoxy-2-methylphenyl ring, which imparts specific pharmacological properties and biological activities.

Recent research has highlighted the potential of 4-(4-methoxy-2-methylphenyl)butanoic acid in various therapeutic areas. For instance, studies have shown that this compound exhibits anti-inflammatory properties, making it a promising candidate for the treatment of inflammatory diseases such as arthritis and inflammatory bowel disease (IBD). The anti-inflammatory effects are attributed to its ability to modulate key signaling pathways involved in the inflammatory response, such as the nuclear factor-kappa B (NF-κB) pathway.

In addition to its anti-inflammatory properties, 4-(4-methoxy-2-methylphenyl)butanoic acid has been investigated for its potential as an antitumor agent. Preclinical studies have demonstrated that this compound can inhibit the growth of various cancer cell lines, including those derived from breast, lung, and colon cancers. The mechanism of action involves the induction of apoptosis and the inhibition of cell proliferation through the modulation of cell cycle regulatory proteins.

The pharmacokinetic profile of 4-(4-methoxy-2-methylphenyl)butanoic acid has also been studied extensively. Research indicates that it has good oral bioavailability and a favorable distribution profile, allowing it to reach target tissues effectively. Furthermore, the compound has been shown to have low toxicity and minimal side effects in preclinical models, which enhances its potential as a therapeutic agent.

In the context of drug development, 4-(4-methoxy-2-methylphenyl)butanoic acid has been evaluated in several preclinical studies to assess its efficacy and safety. These studies have provided valuable insights into its pharmacological properties and potential therapeutic applications. For example, a recent study published in the Journal of Medicinal Chemistry reported that this compound exhibited potent anti-inflammatory activity in both in vitro and in vivo models of inflammation.

The structural modifications of 4-(4-methoxy-2-methylphenyl)butanoic acid have also been explored to enhance its therapeutic potential. Researchers have synthesized various derivatives by altering the substituents on the phenyl ring or modifying the butanoic acid chain. These modifications have led to compounds with improved potency, selectivity, and pharmacokinetic properties. For instance, one derivative with an additional hydroxyl group on the butanoic acid chain showed enhanced anti-inflammatory activity compared to the parent compound.

The potential applications of 4-(4-methoxy-2-methylphenyl)butanoic acid extend beyond inflammation and cancer. Recent studies have also explored its use in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Preliminary findings suggest that this compound may have neuroprotective effects by reducing oxidative stress and inhibiting neuroinflammation. These findings open up new avenues for further research and development in the field of neurodegenerative disorders.

In conclusion, 4-(4-methoxy-2-methylphenyl)butanoic acid (CAS No. 6307-30-8) is a promising compound with a wide range of potential therapeutic applications. Its unique chemical structure and pharmacological properties make it an attractive candidate for further investigation in medicinal chemistry and pharmaceutical research. Ongoing studies are expected to provide more insights into its mechanisms of action and therapeutic potential, paving the way for its development as a novel therapeutic agent.

• 1929-29-9(3-(4-Methoxyphenyl)propanoic acid)
• 4521-28-2(4-(4-Methoxyphenyl)butyric acid)
• 10516-71-9(3-(3-methoxyphenyl)propanoic acid)
• 717-94-2(3-(3,5-Dimethoxyphenyl)propanoic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)